EurekaMag
+ Translate
+ Most Popular
Sobre os generos Lopadusa Stal e Bothrocoris Mayr (Hemiptera, Pentatomidae, Pentatomini)
RFEF pilot plant for inactivation of Escherichia coli in apple juice
Calpionella alpina Lorenz als "Leitfossil"
Sooretama: The Atlantic Rain Forest of Brazil. Francis Dov Por
Novel approaches in myeloma therapy
Preliminary Notes on the Study of Mitochondria During the 1st Stages of the Destruction of Cadavers
A preliminary study of the biology of lichee stink bug, Tessaratoma papulosa Drury, and its control
The status of the Sabu Island python - Die Situation des Savu-Pythons
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. the UK Group for Immunoglobulin Replacement therapy in Multiple Myeloma
Conflicts between children
Clinical presentations in neuropsychiatry
Method of suturing a perforated ulcer of the stomach and duodenum
Identification of mechanical asphyxiation in cases of attempted masking of the homicide
Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig
Is it warm? Is it real? Or just low spatial frequency?
Additions and corrections to the list of Korean Heteroptera
Factors contributing to the maintenance of oligotrophy in an alpine glacial moraine lake (Wallowa lake) in Northeast Oregon
Classification, paleoecology, and biostratigraphy of crinoids from the Stull Shale (Late Pennsylvanian) of Nebraska, Kansas, and Iowa
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Neue Formen der Bauchsammler aus Turkmenien (Hymenoptera, Apoidea)
Atypische Hühnerpest und Newcastle-Krankheit. Ein Identifizierungsversuch
Parasitellus fucorum in the debris of Apis mellifera - a risk of confusion with Tropilaelaps spp
Applying the Technology Acceptance Model to the introduction of healthcare information systems
Ein akarologischer Nachruf für den "Roland"
Mutation research on crop plants in Argentina

Clinical use of serum and urine bone markers in the management of osteoporosis


Clinical use of serum and urine bone markers in the management of osteoporosis



Current Medical Research and Opinion 21(7): 1015-1026



ISSN/ISBN: 0300-7995

PMID: 16004668

DOI: 10.1185/030079905x49635

Osteoporosis is a common disease characterized by decreased bone mass, increased bone turnover, and increased susceptibility to fracture. Almost 44 million Americans are estimated to have low bone mass, which puts them at increased risk of developing osteoporosis and fractures. Osteoporosis is diagnosed by a low bone density (BMD) measurement, because a low BMD is known to contribute to increased fracture risk, which is the main source of morbidity and mortality for osteoporosis. However, changes in bone mass and density in response to anti-resorptive therapy account for only a small portion of the predicted fracture risk reduction. Whereas dynamic changes in bone turnover, estimated by measurement of bone biochemical markers, such as breakdown products of type-I collagen and proteins secreted by osteoblasts and osteoclasts in blood and urine, can account for a major portion of anti-fracture efficacy of anti-resorptive agents. Most anti-resorptive agents act by rapidly reducing bone markers. This has led to advocacy for use of bone turnover markers, in complement to BMD measurement, in the management of osteoporosis. In general, higher bone turnover is associated with accelerated bone loss and potential deterioration in bone quality. Several clinical trials have established the potential utility of markers to identify patients with rapid bone loss, to aid in therapeutic decision-making, and to monitor therapeutic efficacy of various treatments. Elevated marker levels have been shown to be associated with increased risk of fracture in elderly women, but their utility in predicting fracture is not yet established. In this article, we provide a brief summary to primary practitioners about the role bone markers can play in the management of osteoporosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048559719

Download citation: RISBibTeXText

Related references

Comparison of changes in serum bone markers for various osteoporosis management regimens. Journal of Bone and Mineral Research 17(Suppl 1): S318, 2002

Clinical usefulness of bone turnover markers in the management of osteoporosis. Rinsho Byori. Japanese Journal of Clinical Pathology 61(9): 852-859, 2013

Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. Clinical Biochemist. Reviews 27(3): 123-138, 2006

The role of biochemical markers of bone turnover in osteoporosis management in clinical practice. Clinical Biochemist. Reviews 27(3): 119-121, 2006

The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine 52(2): 222-225, 2016

Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. Seminars in Arthritis and Rheumatism 41(2): 157-169, 2011

Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis. Calcified Tissue International 39(4): 230-233, 1986

Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis. Calcified Tissue International 40(2): 117-117, 1987

Serum bone gla protein and other markers of bone metabolism in hemiplegic osteoporosis. Calcified Tissue International 41(Suppl 2): 54, 1987

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis. Clinical Interventions in Aging 13: 1383-1389, 2018

Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis. Critical Reviews in Clinical Laboratory Sciences 45(2): 221-258, 2008

Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. International Journal of Clinical and Experimental Medicine 8(9): 16352-16357, 2015

Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis. Endocrine Regulations 35(4): 201-208, 2001

Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Chinese Medical Journal 126(13): 2480-2484, 2013

Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertility and Sterility 79(4): 919-924, 2003